A series of Mannich bases having piperidine moiety were reacted with 2-mercaptoethanol, leading to 1-aryl-3-piperidine-4-yl-1-propanone hydrochlorides. The cytotoxicity and carbonic anhydrase inhibitory activities of these new compounds were evaluated. Among the compounds, only one derivative, nitro substituent bearing EU9, showed an effective cytotoxicity, although weak tumor specificity against human oral malignant versus nonmalignant cells. The compound induced apoptosis in HSC-2 oral squamous cell carcinoma cells, but not in human gingival fibroblast. Chemical modifications of this lead are thus necessary to further investigate it as a drug candidate and to obtain compounds with a better activity profile.
Introduction
Cancer is the second cause of death after cardiovascular disorders. Although a great amount of improvements have been made in cancer chemotherapy, there is still need for new selective cytotoxic anticancer agents because of the problems available against the drugs that are on market such as gained resistance, low selectivity and stability. Mannich bases are an important group of compounds in medicinal chemistry and they may be synthesized by applying the reaction discovered by Mannich [1] [2] [3] [4] [5] . These compounds have a wide range of biological activities such as carbonic anhydrase (CA, EC 4.2.1.1) inhibitory [1] [2] [3] , cytotoxic [2] [3] [4] [5] [6] [7] , anti-inflammatory 8 and anticonvulsant activities 9, 10 . The reported mechanism action of the Mannich bases are based on thiol alkylation [11] [12] [13] [14] , interaction with enzymes that are important for antioxidant mechanisms 7 , inhibition of mitochondrial respiration 15, 16 , inhibition of topoisomerase enzyme 17 as well as tubulin polimerization inhibition 18 . The CAs are that enzymes play important roles in physiological and pathological processes 19 . Sixteen CA isoforms have been identified in mammals. Many CA isoforms take part in several vital biological processes such as electrolyte secretion, acid-base balance, ion transport and lipogenesis, ureagenesis and bone resorption. Inhibitors or activators of these enzymes have medical applications such as diuretics, in the treatment of glaucoma, neurological disorders including epilepsy and antitumor drugs targeting hypoxic tumors that overexpress some CA isoforms (e.g. CA IX and XII) [19] [20] [21] [22] [23] [24] [25] . The aim of this study was to synthesize 1-aryl-3-(2-hydroxyethylthio)-1-propanones starting from mono Mannich bases (1-aryl-3-piperidine-4-yl-1-propanone hydrochlorides) and to investigate their cytotoxic and CA inhibitory activities against human (h) isoforms hCA I and II.
Materials and methods

1
H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were taken using a Varian spectrometer (Danbury, CT). Chemical shifts (d) were reported in ppm. Melting points were determined using an Electrothermal 9100 (IA9100, Bibby Scientific Limited, Staffordshire, UK) instrument and are uncorrected. Mass spectra was taken using a MS (ESI-MS) VG Waters Micromass ZQ (Waters Corporation, Milford, MA). All reactions were carried out in CEM Discover Microwave Synthesis Systems (CEM, Matthews, NC).
Chemistry
Synthesis of 1-aryl-3-piperidin-4-yl-1-propanone hydrochlorides (B1-B9)
A mixture of the appropriate ketone, paraformaldehyde and piperidine hydrochloride in acetic acid (10 mL) was heated in microwave oven at 70 Watt and 120 C for 20-65 min (Scheme 1). Reactions were monitored by thin-layer chromatography (TLC) using CHCl 3 :CH 3 OH (8:2 or 9:1) solvent system. When the reaction finished, reaction solvent was removed under vacuum and the crude solid was crystallized from suitable solvent such as CH 3 OH, CHCl 3 /CH 3 OH or CH 3 OH/Et 2 O to obtain B1-B9.
Chemical structure of the compounds were confirmed by 1 H NMR and melting points reported (data were not shown since they are reported in literatures).
Synthesis of 1-aryl-3-(2-hydroxyethylthio)-1-propanones (EU1-EU9, Scheme 1)
A mixture of 2-mercaptoethanol and a suitable compound of 1-aryl-3-piperidin-4-yl-1-propanone hydrochloride (B1-B9) in a phosphate buffer solution (5 mL, pH ¼ 7.4) was shaken at 37 C. Reactions were monitored by TLC. When the reaction was stopped, reaction content was extracted with CHCl 3 (3 Â 10 mL) and then with distilled water (3 Â 10 mL). Organic phase was dried on anhydrous sodium sulfate. Solvent was removed under vacuum. Crude compounds were purified by column chromatography on silica gel 60 (70-230 mesh) using ethylacetate:hexane (8:2) solvent system as a mobile phase to obtain a suitable compound of EU.
During the synthesis of EU2, EU3, EU5, EU8 and EU9 Mannich bases used (B2, B3, B5, B8 and B9) did not consumed in the reaction medium, although reactions were continued for 77-96 h. The compounds EU2, EU3, EU5 and EU6 were solid, while the compounds EU1, EU7, EU8 and EU9 were viscous liquid. EU4 was solid at +4 C, while it was viscous liquid at room temperature. Experimental and spectral details of EU1-EU9 are presented in Tables 1 and 2 , respectively.
Biological activity
Cytotoxicity assay
The compounds were assayed toward human oral squamous cell carcinoma cell lines (HSC-2, HSC-3, HSC-4), human promyelocytic leukemic cell line (HL-60) and human oral normal mesenchymal cells (gingival fibroblast (HGF), pulp cells (HPC) and periodontal ligament fibroblast (HPLF)) based on a literature procedure with some minor modifications [26] [27] [28] . In brief, cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) except the HL-60 cells that were cultured in RPMI 1640 medium supplemented with 10% FBS. Varying concentrations of the compound in dimethylsulfoxide were added to the medium and incubated at 37 C for 48 h. The viable cell numbers were determined by the MTT method except for HL-60 cells, the viable cell number of which was counted with a hemocytometer after staining with 0.15% trypan blue. The 50% cytotoxic concentration (CC 50 ) value was determined from the growth curves plotted at different concentrations of each compounds in triplicate wells. Calculation of tumor-specificity (TS) index: The TS value was calculated by dividing the mean CC 50 value of each compound against normal cells to mean CC 50 value against OSCC.
Immunoblot analysis
Primary antibodies against cPARP were purchased from Cell Signaling Technology (Danvers, MA), and the primary antibody against actin was purchased from Sigma-Aldrich (St. Louis, MO). The horseradish peroxidase-conjugated secondary anti-mouse immunoglobulin G (IgG) and anti-rabbit IgG antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). The HSC-2 and HGF cells were cultured in six well plates for 24 h and then incubated with the compound for 24 h. The cells were scraped with a rubber policeman and collected in 10 Â cell lysis buffer (Cell Signaling Technology, Beverly, MA) supplemented with 1 mM phenylmethanesulfonyl fluoride plus one tablet of protease inhibitor cocktail (Complete, EDTA-free; Roche Diagnostics GmbH, Mannheim, Germany). Aliquots of the lysates (50 mg protein) were subjected to SDS-polyacrylamide gel electrophoresis, followed by immunoblotting with primary antibodies against cPARP and actin (employed as a loading control) and secondary anti-IgG antibodies, as previously described 29 . 
Carbonic anhydrase inhibition assay
An Applied Photophysics stopped-flow instrument has been used for assaying the CA-catalyzed CO 2 hydration activity by using the method of Khalifah 30 . Phenol red (at a concentration of 0.2 mM) has been used as indicator, working at the absorbance maximum of 557 nm, with 20 mM Hepes (pH 7.5) as buffer, and 20 mM Na 2 SO 4 (for maintaining constant the ionic strength), following the initial rates of the CA-catalyzed CO 2 hydration reaction for a period of 10-100 s. The CO 2 concentrations ranged from 1.7 to 17 mM for the determination of the kinetic parameters and inhibition constants. For each inhibitor, at least six traces of the initial 5-10% of the reaction have been used for determining the initial velocity. The uncatalyzed rates were determined in the same manner and subtracted from the total observed rates. Stock solutions of inhibitor (0.1 mM) were prepared in distilled and deionized water and dilutions up to 0.01 nM were done thereafter with the assay buffer. Inhibitor and enzyme solutions were preincubated together for 15 min at room temperature prior to assay, in order to allow for the formation of the E-I complex. The inhibition constants were obtained by nonlinear least-squares methods using PRISM (www.graphpad.com), and nonlinear least squares methods, values representing the mean of at least three different determinations, as described earlier by us 31 . All enzymes used were recombinant, produced in E. coli and the cell pellets were lysed and enzyme was purified through affinity chromatography using pAMBS resin as reported earlier 24, [32] [33] [34] .
Results and discussion
In this study, the designed compounds, 1-aryl-3-(2-hydroxyethylthio)-1-propanones, were successfully synthesized by the Table 2 . Spectral data of the compounds EU1-EU9. 85 (m, 2H), 7.49-7.46 (m, 1H), 7.38-7.34 (m, 2H), 3.72-3.68 (m, 2H), 3.50 (brs, OH, 1H) 36 had been reported before. The compounds were synthesized with the yield of 19-89%. EU2, EU3, EU5 and EU6 were solid, while EU1, EU7, EU8 and EU9 were viscous liquid. EU4 was solid at +4 C, while it was viscous liquid at room temperature.
Among the nine compounds reported here, derivatives EU1, EU2, EU3, EU4, EU7 and EU8 were cytotoxic above 400 mM toward both cancer and normal cells. Therefore, the calculation of tumor-specific (TS) value was practically impossible. EU5 and EU6 showed very weak tumor specificity (TS ! 1.2). EU9 showed the highest TS value (TS ! 1.3), and one-order higher cytotoxicity against both cancer and normal cells as compared with the other derivatives. All compounds had lower TS values than a popular anticancer drugs 5-Fluorouracil (5-FU) and Melphalan (Table 3) .
Most of the cytotoxic compounds induce apoptosis 37, 38 . The breaks in single-strand DNA may be repaired by poly(ADPribose)polymerase (PARP1) 39 . This is the reason why PARP1 test was done by using the compound EU9. EU9 at 50 mM concentration (CC 50 ) induced apoptosis (assessed by the cleavage of PARP1) in HSC-2 (OSCC), but not in HGF cells (normal cells) (Figure 1) .
All compounds inhibited hCA I (23-30%) and hCA II (25-27%) isoenzymes with similar percentages. There was not selectivity toward any of hCA isoenzymes. Inhibitions of these izoenzymes by the compounds studied were lower than the reference compound (Table 4) .
Conclusion
Several new compounds are reported here, being obtained by reaction of a suitable Mannich base, 1-aryl-3-amino-1-propenone hydrochloride, with 2-mercaptoethanol. The 1-aryl-3-(2-hydroxyethylthio)-1-propanone investigated here showed rather low tumor-specificity although they induced apoptosis, suggesting that apoptosis-inducing activity itself does not guarantee the antitumor effects. Chemical modifications of the best compound detected here, EU9, are thus necessary to further evaluate such derivatives for their biological activity, as cytotoxic agents or CA inhibitors [40] [41] [42] [43] . 
